Open AccessA Retrospective Study of the Adjunctive Use of Gabapentin With Benzodiazepines for the Treatment of Benzodiazepine Withdrawal
Author(s) -
Edison Leung,
Daniel Ngo,
Joe A. Espinoza,
Lauren L. Beal,
Catherine C.Y. Chang,
Dalsu A. Baris,
Blake N. Lackey,
Scott D. Lane,
Hanjing Emily Wu
Publication year - 2022
Publication title -
journal of psychiatric practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.395
H-Index - 54
eISSN - 1538-1145
pISSN - 1527-4160
DOI - 10.1097/pra.0000000000000639
Subject(s) - gabapentin , benzodiazepine , lorazepam , medicine , retrospective cohort study , anesthesia , medical record , kindling , psychiatry , epilepsy , receptor , alternative medicine , pathology
Benzodiazepine withdrawal is a widespread problem with potentially severe and deadly consequences. Currently, the only medications available for treating benzodiazepine withdrawal are short-acting and long-acting benzodiazepines. Identifying other drugs to help in treating benzodiazepine withdrawal is necessary. Gabapentin, an anxiolytic drug that is also used off-label to treat alcohol withdrawal, is a potential candidate for modulating benzodiazepine withdrawal. Using electronic records from a large inpatient psychiatric facility, a retrospective study of 172 patients presenting with benzodiazepine withdrawal was conducted to determine if the coincidental use of gabapentin for other medical conditions was associated with better outcomes of benzodiazepine withdrawal (N=57 gabapentin, N=115 no gabapentin). The primary outcomes were hospital length of stay and total amount of benzodiazepines given (lorazepam milligram equivalent). In this retrospective analysis of electronic medical record data, the patients experiencing benzodiazepine withdrawal who received gabapentin as an adjunct to the use of benzodiazepines were administered a smaller amount of benzodiazepines and had a shorter length of hospital stay relative to the comparison group who did not receive adjunctive gabapentin. These results suggest the potential use of gabapentin as an adjunct to the use of benzodiazepines for treating benzodiazepine withdrawal. The limitations of this study included a small sample size and variability in medication management strategies across the sample.